Login
As the 119th Congressional session begins and a new administration takes office, the Obesity Action Coalition (OAC) is excited to continue driving change through advocacy. This year is especially meaningful as we celebrate our 20th Anniversary—a milestone made possible by the passion and dedication of our advocates!
It’s also a transformative time in the obesity space. We’re witnessing a fundamental shift in how society—including our policymakers—understands obesity as a complex, chronic disease.
Here’s an overview of our top policy priorities for 2025:
Congress
As the new House and Senate get to work, OAC is focused on identifying new Congressional champions to carry forward the fight for obesity care. With the retirement of our long-time advocates, Senator Tom Carper (DE) and Representative Brad Wenstrup (OH), we’re seeking leaders who can fill their shoes and advance our mission. Additionally, there are fresh faces and leadership on critical committees such as Ways & Means, Energy & Commerce, and Senate Finance. These changes open the door to new advocacy opportunities for OAC Members and supporters across various districts and states.
Administration
The confirmation process for presidential nominees heading key agencies is underway. These include the Department of Health and Human Services (HHS), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC)—all organizations with which OAC maintains strong working relationships. We look forward to partnering with these agencies at all levels to improve the health and lives of people affected by obesity.
CMS Proposed Rule
One of the most significant milestones in 2024 was the CMS Proposed Rule to expand coverage for obesity medications under Medicare and Medicaid. In 2025, this critical work continues with the 60-day Public Comment period, ending January 27th. Afterward, CMS will review the input and issue a finalized rule. For weeks, the OAC has encouraged advocates to submit comments supporting expanded coverage for obesity medications. If approved, Medicare coverage would begin in 2026, with Medicaid coverage potentially starting within 60 days of the finalized rule.
To learn more about the CMS Proposed Rule and voice your support, click here!
Treat and Reduce Obesity Act (TROA)
Once new Congressional champions are identified, we anticipate the reintroduction of the Treat and Reduce Obesity Act (TROA). The 118th Congress saw unprecedented progress for this legislation, with a narrow version of the bill passing out of the Ways and Means Committee with bipartisan support. Although TROA was considered for inclusion in end-of-year legislation, it was ultimately excluded due to the release of the CMS proposed rule. Moving forward, legislation will still be required to establish Medicare Part D coverage and to expand Part B coverage to include additional providers and care settings.
Regulatory Policy
The OAC will continue our work with the FDA to ensure safe and transparent drug labeling practices and to advocate for the inclusion of individuals with obesity in clinical trials. Additionally, we will closely monitor and evaluate state and federal policy developments related to GLP-1 compounding to ensure that patients’ needs are prioritized.
State Advocacy
Grassroots efforts will remain a foundation of our advocacy strategy in 2025. OAC will continue leading initiatives in our 10 priority states while addressing coverage issues as they arise nationwide. Already, legislation has been introduced in Colorado, Indiana, New York and Connecticut. These efforts focus on improving access to care under Medicaid, ACA Exchange plans and other state-regulated insurance programs. Stay informed by visiting the OAC Action Center for updates and opportunities to get involved.
Support OAC’s advocacy work by donating to our Action Fund! The OAC Action Fund helps us increase visibility on key issues, meet with legislators and policymakers, mobilize quickly when issues arise, and much more. Make a donation today!